31 March 2020

A Statement from Carter BloodCare on Convalescent Plasma

Carter BloodCare is working with doctors and hospitals to facilitate the collection of convalescent plasma under the U.S. Food and Drug Administration’s (FDA) Emergency Investigational New Drug (eIND) guidance. The FDA’s web site outlines the protocols for physicians who want to participate in the Investigational COVID-19 Convalescent Plasma - Emergency INDs.

12 March 2020

“We need people to start turning out in force to give blood.”

“We need people to start turning out in force to give blood.” That urgent call-to-action coming from Peter Marks, M.D., Ph.D., director of the U.S. Food and Drug Administration’s (FDA) Center for Biologics Evaluation and Research, as fear about the coronavirus is keeping people from wanting to donate blood.

Over the past week, blood centers throughout the country are experiencing a significant drop in donations which is limiting the ability for the nation’s blood supply to be adequately replenished.

12 March 2020

A Message from President and CEO Dr. Merlyn Sayers

Blood donation remains safe. The first line of protection for the blood supply is the routine health screening of donors. This includes our asking if you are healthy and feeling well on the day of donation. If you have any symptoms of illness, including cold or flu, you should not present to give blood. Blood donors are routinely screened for temperature, pulse rate, blood pressure and hemoglobin. Carter BloodCare encourages all eligible blood donors to make and keep appointments; and for sponsors to continue hosting blood drives.

10 March 2020

Coronavirus Fears Put Nation’s Blood Supply at Risk

Concerns over the coronavirus are negatively impacting the nation’s blood supply and it has blood centers around the country appealing to the public that now is the time to donate.

 

 

08 March 2020

Carter BloodCare responds to shortage due to COVID-19

Carter BloodCare has responded to a plea for help from a Seattle-area community blood center by shipping 100 units of type O Rh positive blood. Bloodworks Northwest is responsible for supplying blood products to hospitals that are in the middle of ground zero for the COVID-19 outbreak in the U.S. The blood program reported 12 canceled blood drives by one of the region’s largest employers. Additionally, schools and universities have closed and businesses are implementing employee telecommuting. One blood banking executive called it ‘the perfect storm for a blood shortage.’

06 March 2020

Carter BloodCare remains vigilant during evolving COVID-19 outbreak

Carter BloodCare recognizes that there are concerns surrounding the COVID-19 outbreak. As your community blood center, be reassured that we are closely monitoring disease progression. We have daily communications with AABB, the U.S. Food and Drug Administration (FDA) and the Centers for Disease Control (CDC). The blood banking community members also remain in close contact with each other about best practices. Carter BloodCare’s mission is at the heart of what we do – saving lives by making transfusion possible.

03 March 2020

Carter BloodCare remains vigilant during evolving COVID-19 outbreak

Carter BloodCare recognizes that there are concerns surrounding the COVID-19 outbreak. As your community blood center, be reassured that we are closely monitoring disease progression. We have daily communications with AABB, the U.S. Food and Drug Administration (FDA) and the Centers for Disease Control (CDC). The blood banking community members also remain in close contact with each other about best practices. Carter BloodCare’s mission is at the heart of what we do – saving lives by making transfusion possible.